XML 61 R96.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplemental Condensed Consolidating Financial Statements (Details 3) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 29, 2012
Sep. 29, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Oct. 01, 2011
Jul. 02, 2011
Apr. 02, 2011
Dec. 29, 2012
Dec. 31, 2011
Jan. 01, 2011
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance       $ 8,374       $ 991 $ 8,374 $ 991 $ 50,820
Net (loss) income (11,370) [1] 3,068 [2] (3,706) [3] (11,019) [4] (10,252) [5] (6,208) [6] (9,781) [7] (12,326) [8] (23,027) (38,567) (53,243)
Foreign currency translation adjustment, net of tax                 103 (92) 336
Unrealized (loss) gain from pension plan, net of taxes                 (8,245) (14,969) (616)
Unrealized gain from cash flow hedge, net of tax                   519 1,297
Issuance of restricted stock, net of forfeitures                 19 7 7
Repurchase of common stock                     (583)
Issuance of stock related to the rights offering, net of expenses                   58,521  
Compensation related to share-based grants                 2,730 2,158 3,876
Reclassification of equity awards to liability                     (903)
Impact of net settled shares for vested grants                 (526) (194)  
Other                 (20)    
Net transactions with Parent                        
Balance (20,592)       8,374       (20,592) 8,374 991
BlueLinx Holdings Inc.
                      
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance       8,374       991 8,374 991 50,820
Net (loss) income                 (23,027) (38,567) (53,243)
Foreign currency translation adjustment, net of tax                 103 (92) 336
Unrealized (loss) gain from pension plan, net of taxes                 (8,245) (14,969) (616)
Unrealized gain from cash flow hedge, net of tax                   519 1,297
Issuance of restricted stock, net of forfeitures                 19 7 7
Repurchase of common stock                     (583)
Issuance of stock related to the rights offering, net of expenses                   58,521  
Compensation related to share-based grants                 2,730 2,158 3,876
Reclassification of equity awards to liability                     (903)
Impact of net settled shares for vested grants                 (526) (194)  
Other                 (20)    
Net transactions with Parent                         
Balance (20,592)       8,374       (20,592) 8,374 991
BlueLinx Corporation and Subsidiaries
                      
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance       83,626       94,273 83,626 94,273 142,363
Net (loss) income                 (37,237) (52,910) (50,243)
Foreign currency translation adjustment, net of tax                 103 (92) 336
Unrealized (loss) gain from pension plan, net of taxes                 (8,245) (14,969) (616)
Unrealized gain from cash flow hedge, net of tax                   519 1,297
Issuance of restricted stock, net of forfeitures                 19      
Repurchase of common stock                       
Issuance of stock related to the rights offering, net of expenses                       
Compensation related to share-based grants                         
Reclassification of equity awards to liability                       
Impact of net settled shares for vested grants                        
Other                       
Net transactions with Parent                 2,337 56,805 1,136
Balance 40,603       83,626       40,603 83,626 94,273
LLC Subsidiaries
                      
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance       (124,175)       (140,314) (124,175) (140,314) (154,118)
Net (loss) income                 18,536 18,530 6,770
Foreign currency translation adjustment, net of tax                         
Unrealized (loss) gain from pension plan, net of taxes                         
Unrealized gain from cash flow hedge, net of tax                        
Issuance of restricted stock, net of forfeitures                         
Repurchase of common stock                       
Issuance of stock related to the rights offering, net of expenses                       
Compensation related to share-based grants                         
Reclassification of equity awards to liability                       
Impact of net settled shares for vested grants                        
Other                       
Net transactions with Parent                 (2,017) (2,391) 7,034
Balance (107,656)       (124,175)       (107,656) (124,175) (140,314)
Eliminations
                      
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance       40,549       46,041 40,549 46,041 11,755
Net (loss) income                 18,701 34,380 43,473
Foreign currency translation adjustment, net of tax                 (103) 92 (336)
Unrealized (loss) gain from pension plan, net of taxes                 8,245 14,969 616
Unrealized gain from cash flow hedge, net of tax                   (519) (1,297)
Issuance of restricted stock, net of forfeitures                 (19)      
Repurchase of common stock                       
Issuance of stock related to the rights offering, net of expenses                       
Compensation related to share-based grants                         
Reclassification of equity awards to liability                       
Impact of net settled shares for vested grants                        
Other                       
Net transactions with Parent                 (320) (54,414) (8,170)
Balance $ 67,053       $ 40,549       $ 67,053 $ 40,549 $ 46,041
[1] During the three months ended December 29, 2012, basic and diluted weighted average shares were 60,118,183, respectively. Total share-based awards of 4,460,054 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[2] During the three months ended September 29, 2012, basic and diluted weighted average shares were 60,098,691.
[3] During the three months ended June 30, 2012, basic and diluted weighted average shares were 60,097,558. Total share-based awards of 4,515,590 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[4] During the three months ended March 31, 2012, basic and diluted weighted average shares were 60,002,836. Total share-based awards of 4,519,590 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[5] During the three months ended December 31, 2011, basic and diluted weighted average shares were 59,659,984, respectively. Total share-based awards of 3,266,740 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[6] During the three months ended October 1, 2011, basic and diluted weighted average shares were 51,182,748. Total share-based awards of 3,076,739 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[7] During the three months ended July 2, 2011, basic and diluted weighted average shares were 31,062,794. Total share-based awards of 3,079,540 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[8] During the three months ended April 2, 2011, basic and diluted weighted average shares were 30,843,732. Total share-based awards of 3,096,843 were excluded from our diluted earnings per share calculation because they were anti-dilutive.